| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.46 | 0.007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |